📄 Cross-examination of Collin Yamauchi (morning, part 2) — Tuesday, May 30, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\30\CROSS-EXAMINATION-OF-COLLIN-YA.DOC
TRIAL
▲ Day 84 of 167

Cross-examination of Collin Yamauchi (morning, part 2)

Witness: Collin Yamauchi
Examiner: Barry Scheck
Called by: Prosecution • Date: Tuesday, May 30, 1995 • Utterances: 293
Barry Scheck cross-examines LAPD criminalist Collin Yamauchi about his DNA laboratory procedures, specifically whether he violated his own protocol by extracting OJ Simpson's reference blood sample in the same session, location, and timeframe as evidentiary samples from the Bundy crime scene. The examination ends with a damaging concession: based on Yamauchi's own unnumbered, unordered notes, it appears he sampled the glove before the Bundy swatches — meaning the high-concentration reference blood was handled in close sequence to the glove evidence.
1 (Discussion held off the record between Defense counsel.)
2 MR. SCHECK:

1159-C.

3 MR. SCHECK:

Mr. Yamauchi, was it part of your training to avoid cutting evidence items with high DNA content in the same period and in the same location as you are dealing with evidence of low DNA content?

4 MR. HARMON:

Objection.

5 MR. SCHECK:

Was that part of your training?

6 MR. HARMON:

It is compound, your Honor.

7 THE COURT:

Rephrase the question.

8 MR. SCHECK:

All right.

9 MR. SCHECK:

As part of your training were you given any instruction on how to handle evidence items that might contain high DNA content and low DNA content?

10 MR. YAMAUCHI:

Well, we already went over this. You can't really know whether some items have high DNA or low DNA by looking at them, so falling back to my normal standard procedure, I make sure I don't open up an evidence item along with another one. In other words, I only work on one item at a time so at no time are two items of evidence opened simultaneously, and I think that would address your question, because if I don't have two of them opened simultaneously, then they wouldn't be done at the same time.

11 MR. SCHECK:

Well, so as far as you are concerned, there are no dangers then of first cutting a sample with high DNA content, putting that aside and then moving to a sample with low DNA content?

12 MR. HARMON:

Objection, it is vague, argumentative, misstates his testimony.

13 THE COURT:

Do you understand the question, Mr. Yamauchi?

14 MR. YAMAUCHI:

I believe I do.

15 THE COURT:

All right. Go ahead and answer it.

16 MR. YAMAUCHI:

Once again, if I sample an item and I don't know what the--the contents of DNA is in there, regardless of that, I sampled that, close it off and take care of everything with that one sample first, and only then my samples encased into one of those microcentrifuge tubes, only after all that is capped and everything is closed off will I move on to another sample.

17 MR. SCHECK:

All right. And so as far as you are concerned, as long as you do sample no. 1, then you take sample no. 2, there is no problem?

18 MR. HARMON:

Objection. It is vague, argumentative.

19 THE COURT:

Overruled.

20 MR. YAMAUCHI:

Following my procedure where I close everything off, no, I don't see a problem with that.

21 MR. SCHECK:

Now, let's move to the DNA extraction phase and the DNA amplification phase. Are you with me?

22 MR. YAMAUCHI:

Okay.

23 MR. SCHECK:

On those two phases was it part of your training to avoid analyzing samples with high DNA content and low DNA content in the same series--in the same run of microcentrifuge tubes?

24 MR. YAMAUCHI:

My procedure of only keeping one tube opened at one time and working on one--one sample at a time goes through to my handling in the amplification process also. So at no given time do I have two tubes opened of extract simultaneously. I will only have one opened at each individual time and I will pipette from that into the next step, and in that case those two would be opened, but one is receiving the sample.

25 MR. SCHECK:

So it was never part of your training to avoid the extraction phase or the amplification phase doing in the same run samples with high DNA content and low DNA content just in case there was inadvertent cross-contamination? That is not part of your training.

26 MR. HARMON:

Objection. That is compound.

27 THE COURT:

Overruled. Do you understand the question?

28 MR. YAMAUCHI:

Yes. Once again, they are closed off from each other so there is no way they can contaminate each other.

29 MR. SCHECK:

No way you can make an inadvertence mistake, a mistake you are not aware of?

30 MR. HARMON:

Objection, calls for speculation.

31 THE COURT:

Sustained, sustained.

32 MR. SCHECK:

You received no training to avoid situations with high DNA content and low DNA content samples in analysis to lower the risk of cross-contamination? That is not part of your training?

33 MR. YAMAUCHI:

Once again, the whole procedure by which I sample and do the analyses precludes that from happening because I separate each and everything off from each other.

34 (Discussion held off the record between Defense counsel.)
35 MR. SCHECK:

1159-D.

36 MR. SCHECK:

Is it part of your training not to cut evidence samples from two different crime scenes in the same place during the same period of time?

37 MR. HARMON:

Objection. That is compound.

38 THE COURT:

Sustained.

39 MR. SCHECK:

All right.

40 MR. SCHECK:

In the evidence processing room, within a half hour period taking sample after sample, was it part of your training to avoid cutting samples from different crime scenes in the same series?

41 MR. YAMAUCHI:

Once again, my procedure, I don't allow two items of evidence opened at the same time. I do them one at a time.

42 MR. SCHECK:

So since you do the evidence items one at a time, it doesn't matter to you that you will handle evidence item no. 1 from one crime scene and then you move to evidence item 2 from another crime scene?

43 MR. YAMAUCHI:

It is not happening at the same time.

44 MR. SCHECK:

Well--

45 MR. YAMAUCHI:

I sample everything one by one.

46 MR. SCHECK:

You have--you do a series of five items. Are you with me?

47 MR. YAMAUCHI:

Okay.

48 MR. SCHECK:

Item 1 comes from crime scene no. 1. You finish with that, then you go to item 2 from crime scene no. 2. You to go item number 3 from crime scene no. 3. You go to item 4 from crime scene no. 4, item 5 from crime scene no. 5. No problem with that?

49 MR. YAMAUCHI:

Provided the conditions and the procedure that I use is in effect where I make sure each item of evidence is closed off from the next one to eliminate chances of cross-contamination, that is fine.

50 (Discussion held off the record between Defense counsel.)
51 MR. SCHECK:

1159-F.

52 MR. SCHECK:

Your answer would be the same with respect to handling samples from a suspect and a victim in a series?

53 MR. YAMAUCHI:

Yes. My answer is the same using my protocol and procedure.

54 (Discussion held off the record between Defense counsel.)
55 MR. SCHECK:

1159-E.

56 MR. SCHECK:

Now, Mr. Yamauchi, let's talk about handling reference samples from a suspect and evidence samples. Do you not agree that a reference sample from a suspect creates a special danger of cross-contamination?

57 MR. YAMAUCHI:

If mishandled, of course it would create a danger, but if it is handled correctly, there is no danger.

58 MR. SCHECK:

Would you agree that reference samples contained highly concentrated amounts of DNA?

59 MR. YAMAUCHI:

They have--yeah, they have a good amount of DNA in them.

60 MR. SCHECK:

Well, the blood from a reference sample, you would expect to have--to be much more highly concentrated in terms of its DNA content than the blood swatches that you handled on the morning of June 14th?

61 MR. YAMAUCHI:

How would I know that?

62 MR. SCHECK:

You wouldn't--

63 MR. YAMAUCHI:

You can't tell by--I'm sorry. Can I finish?

64 MR. SCHECK:

I thought you had.

65 MR. YAMAUCHI:

Well--

66 MR. SCHECK:

You asked me how would you know? Let me pose another question to you. Okay?

67 MR. HARMON:

Your Honor, I think he was going to embellish.

68 THE COURT:

Have you completed your answer?

69 MR. YAMAUCHI:

Well, I would like to add something.

70 THE COURT:

All right. Answer the question.

71 MR. YAMAUCHI:

Okay. In terms of looking at swatches, you can't tell the quantity or quality of DNA that is on them just by looking at it. It is not scientifically possible to do that kind of assessment. You can give--you can give a ballpark guess, but you can't know.

72 THE COURT:

Next question.

73 MR. SCHECK:

Mr. Yamauchi, is it not fundamental laboratory practice to assume that the blood from the reference sample of a suspect is going to be much more highly concentrated in terms of its DNA than the sample that you will get from an evidence specimen?

74 MR. YAMAUCHI:

That is not always the case. Sometimes you can get evidence samples that are very concentrated in DNA.

75 MR. SCHECK:

My question to you, sir, is: Isn't it fundamental laboratory practice to assume, when examining a reference sample and examining an evidence sample, that the reference sample is going to have much more highly concentrated DNA?

76 MR. HARMON:

Objection. It is argumentative, no foundation.

77 THE COURT:

Overruled.

78 MR. YAMAUCHI:

No, I can't assume that. I treat all my samples the same way with the same proper precautions that I explained earlier.

79 MR. SCHECK:

So you make no special exception for handling a suspect's reference sample?

80 MR. YAMAUCHI:

Well, I may take a smaller piece, a smaller cutting.

81 MR. SCHECK:

When handling a vacutainer tube with a Defendant's reference sample, there is a danger of aerosols or sprays when the tube is opened?

82 MR. YAMAUCHI:

Well, there is if you just open the cap up, but if you do as I explained earlier, and put chem wipes over the top of the cap and carefully open up the cap, any aerosol that would be caused would be trapped in the chem wipe. And in that way, rest assured that my procedure is good at keeping any such aerosols from contaminating anything else.

83 MR. SCHECK:

And when opening these tubes there tends to be blood on the caps?

84 MR. YAMAUCHI:

Yes.

85 MR. SCHECK:

And that can present a danger, when you handle it, of getting blood from the cap on your hand or on other items?

86 MR. YAMAUCHI:

Well, yes, and I keep the cap inside of the wad of chem wipes.

87 MR. SCHECK:

And when you are handling a reference tube, there is a danger in opening it of spills?

88 MR. YAMAUCHI:

Well, anytime you hold a vial or a glass of liquid there is a danger of a spill.

89 MR. SCHECK:

And when you are handling these fitzco--you make a fitzco card by pouring how many drops of blood in each of the four quadrants of the card?

90 MR. YAMAUCHI:

I said approximately 250 microliters, 200 to 250, and I don't pour it out of the tube; I use a pipetter.

91 MR. SCHECK:

And how many drops would it take to fill up one of those 250 to 500 microliter quadrants in the card?

92 MR. YAMAUCHI:

I think I said 200 to 250.

93 MR. SCHECK:

How many drops? 200 to 250.

94 MR. YAMAUCHI:

Microliters.

95 MR. SCHECK:

Yes.

96 MR. YAMAUCHI:

How many drops?

97 MR. SCHECK:

Yes, for each quadrant?

98 MR. YAMAUCHI:

You know, I couldn't tell you.

99 MR. SCHECK:

And these cards are wet when you first drop the blood on them?

100 MR. YAMAUCHI:

Are they wet before I drop the blood on them?

101 MR. SCHECK:

No, afterward?

102 MR. YAMAUCHI:

Well, blood is wet. Obviously it is going to be wet after you drop the blood on the card.

103 MR. SCHECK:

Right. And in handling those cards one must protect against the danger of cross-contamination with reference blood?

104 MR. YAMAUCHI:

Yes.

105 MR. SCHECK:

Now, is it part of your training that evidence samples and known exemplars or reference samples be extracted at different times and/or locations?

106 MR. HARMON:

Objection. That is compound, your Honor.

107 THE COURT:

Sustained.

108 MR. SCHECK:

Have you ever heard the expression that evidence sample and known exemplars be extracted at different times and/or locations?

109 MR. YAMAUCHI:

Once again, my whole practice and procedure allows for every evidence item to be handled separately from another, so it is always happening at a separate time and place. I make sure that none of my evidence is opened up simultaneously. I--once again, I open up an item of evidence, I work on that. After I'm done, I close that off and make sure it is away and in no way allowing the opportunity for that to contaminate with anything else, and then I go onto the next item.

110 MR. SCHECK:

Mr. Yamauchi, my question to you has--was not for you to repeat again, but my question was have you ever heard the phrase that evidence samples and known exemplars are extracted at different times and/or locations? Have you ever heard that?

111 MR. YAMAUCHI:

Yes, and once again, my protocol--

112 MR. SCHECK:

The answer is yes?

113 MR. YAMAUCHI:

--protocol addresses that--

114 MR. SCHECK:

The answer is yes, right?

115 MR. YAMAUCHI:

That is what I said, yes.

116 MR. SCHECK:

Thank you. And that is in fact a phrase that is in section 25 of your protocol?

117 MR. YAMAUCHI:

Well, I can take your word for it or you can show it to me.

118 MR. SCHECK:

Well, first, does it ring a bell with you as an important phrase or admonition?

119 MR. YAMAUCHI:

It sounds familiar, yes.

120 MR. SCHECK:

All right. I show you this document. I call your attention to the last paragraph there. Does that refresh your recollection as to what your protocol contains?

121 MR. YAMAUCHI:

Yes.

122 MR. SCHECK:

Do you rely on that section, that paragraph that is contained in section 25 of your protocol?

123 MR. YAMAUCHI:

Yes.

124 MR. SCHECK:

That is under the section of "Quality assurance program"?

125 MR. YAMAUCHI:

Yes.

126 MR. SCHECK:

And this section says: "To assure that no contamination occurs between known samples and evidentiary samples in a case, the exemplars and evidentiary samples are extracted at different times and/or locations," right?

127 MR. YAMAUCHI:

Yes.

128 MR. SCHECK:

Now, first of all, let's get some phrases down. Do you take it to mean that known samples and exemplars would refer to a suspect's reference sample?

129 MR. YAMAUCHI:

Yes.

130 MR. SCHECK:

Now, do you interpret this section of your protocol to permit you to do an extraction of the Defendant's reference sample in the same run as evidentiary samples?

131 MR. YAMAUCHI:

Yes, and that is the whole idea behind the precautions that I take, to make sure that I don't open up more than one evidence item at the same time and so on and so forth with the tubes that are being transferred from one extraction into the amplification tube. These are not allowing any more than one tube to be opened at a time.

132 MR. SCHECK:

Now--

133 MR. YAMAUCHI:

And that is the reason why I do it that way, to address that particular issue.

134 MR. SCHECK:

You think that when you are handling a series of tubes that contained evidence samples and one that contains the Defendant's reference samples in one run that you are complying with that section of the protocol?

135 MR. HARMON:

Objection. That is argumentative, your Honor.

136 THE COURT:

Sustained. Rephrase the question.

137 MR. SCHECK:

All right.

138 MR. SCHECK:

Let's assume, as you have stated, that you are opening each of the tubes that contains the samples and closing them one after another.

139 MR. YAMAUCHI:

I only open one at a time.

140 MR. SCHECK:

You open one at a time. Let's assume that. Okay?

141 MR. YAMAUCHI:

Okay.

142 MR. SCHECK:

Do you interpret your protocol as permitting you to do extractions with this series of tubes, all right, in one extraction session, including the Defendant's reference sample and evidentiary specimens, as long as you do them one at a time?

143 MR. YAMAUCHI:

Provided the strict precautions that I use in handling my evidence is taken into consideration, that is all right.

144 MR. SCHECK:

So you interpret the phrase "At different locations and/or times" in a way that doesn't include a situation such as this case, where you handled Mr. Simpson's reference--you extracted Mr. Simpson's reference sample on the morning of June 14th in the same series where you did the Bundy samples?

145 MR. HARMON:

Objection. It is vague, compound, argumentative.

146 THE COURT:

Sustained.

147 MR. SCHECK:

Let me try it this way: On the morning of June 14th you did an extraction on Mr. Simpson's reference sample?

148 MR. YAMAUCHI:

Yes.

149 MR. SCHECK:

On the morning of June 14th you did an extraction on the Bundy samples?

150 MR. YAMAUCHI:

Yes.

151 MR. SCHECK:

That was in the series of 23 tubes that you were doing in one day?

152 MR. YAMAUCHI:

Yes.

153 MR. SCHECK:

And you did those extractions in the serology laboratory?

154 MR. YAMAUCHI:

Yes.

155 MR. SCHECK:

And you did it in your hood?

156 MR. YAMAUCHI:

Part of the time.

157 MR. SCHECK:

And the location was either your hood or your desk right next to the hood where you were doing these extractions?

158 MR. YAMAUCHI:

My work station and the hood, yes.

159 MR. SCHECK:

That was the location?

160 MR. YAMAUCHI:

Locations.

161 MR. SCHECK:

And the time that it took you to do the extraction on these 23 tubes was how long?

162 MR. YAMAUCHI:

It is approximately an hour and a half that that process would take place over.

163 MR. SCHECK:

And as far as you are concerned, your protocol says it is perfectly all right to handle Mr. Simpson's reference tubes along with those 23 samples in that location during that timing period? That is perfectly fine?

164 MR. YAMAUCHI:

Sure, provided you take the precautions that I take.

KEY QUOTE
165 MR. SCHECK:

Did you hear Dr. Cotton testify as to the precaution that she takes in terms of extracting reference samples separate from other extractions up until the amplification phase, and I'm referring to page 277305 of Dr. Cotton's testimony?

166 MR. HARMON:

Objection, still hearsay, beyond the scope, your Honor.

167 THE COURT:

Sustained.

168 MR. SCHECK:

Are you familiar with the practices of other laboratories in terms of extracting evidence samples and Defendant's reference samples?

169 MR. YAMAUCHI:

I'm not familiar with other People's protocols and procedures. I just know that we have ours and it has got a lot of bases back to the Roche user guide.

170 MR. SCHECK:

In terms of your training, did you investigate the methods used by other laboratories in terms of extracting reference samples and evidentiary samples?

171 MR. YAMAUCHI:

Did I--did I investigate other People's protocols and procedures as to that?

172 MR. SCHECK:

Yes.

173 MR. YAMAUCHI:

No, I don't think so.

174 MR. SCHECK:

You said you have some recollection of the CACLD studies. Does that recollection include anything about how a false positive occurred in terms of extracting a suspect's reference sample at the same time as evidentiary specimens?

175 MR. HARMON:

Objection, hearsay, beyond the scope.

176 THE COURT:

Sustained.

177 MR. SCHECK:

Now, before discussing the way you handled Mr. Reference--Mr. Simpson's reference tube and evidentiary specimens in the evidence processing room on the morning of June 14th, I would like to ask you a few questions about your note keeping practices. Have you taken a look at the way notes are prepared at the Department of Justice?

178 MR. YAMAUCHI:

I haven't seen their notes.

179 MR. SCHECK:

Did you have--did you see any of the testimony with respect to note taking from Gary Sims or Renee Montgomery?

180 MR. HARMON:

Objection. Calls for hearsay, beyond the scope.

181 THE COURT:

Overruled. He can say whether or not he saw that.

182 MR. YAMAUCHI:

No, I don't recall.

183 MR. SCHECK:

Do you believe it is important that notes are detailed with respect to the order in which samples are handled?

184 (No audible response.)
185 MR. SCHECK:

Laboratory notes?

186 MR. YAMAUCHI:

Would you be more specific?

187 MR. SCHECK:

I will try. Do you think that laboratory notes should be specific as to the order in which the analyst handles samples?

188 MR. YAMAUCHI:

You mean write out what time or everything that you handle each sample?

189 MR. SCHECK:

Well, let's just start with order and not with specific time. Should your notes reflect the order in which you handled samples and performed analysis on samples?

190 MR. HARMON:

Objection. That is compound, your Honor.

191 THE COURT:

Sustained.

192 MR. SCHECK:

Start with ordered samples--handled samples. Should they reflect the order in which you handled samples?

193 MR. YAMAUCHI:

Notes--the reason why anybody takes notes is to ensure that--

194 MR. SCHECK:

Move to strike as unresponsive. My question is simply this--

195 THE COURT:

Sustained. Do you understand the question, sir? Is it important to note the order in which samples are handled?

196 MR. YAMAUCHI:

I would say that it is important, but it is not the most critical issue of note taking.

197 MR. SCHECK:

Is that something that you do in your notes in terms--do you list the order in which you will handle samples?

198 MR. YAMAUCHI:

Well, in my descriptive notes it come out that way because obviously I'm working on one item and so I've got to describe that, and so on and so forth down the line.

199 MR. SCHECK:

And when you are referring to descriptive notes, would that include the pages that you made out on June 14th on your serology item description sheets?

200 MR. YAMAUCHI:

Yes. That is--that would be what I'm referring to.

201 MR. SCHECK:

And how many pages do you have, referring to your handling of samples on the morning of June 14th and June 15th, these serology item description notes?

202 (No audible response.)
203 MR. SCHECK:

Do you have a total of five pages, sir?

204 MR. YAMAUCHI:

Yes.

205 MR. SCHECK:

All right. Are they numbered in any particular order?

206 MR. YAMAUCHI:

No, they are not.

207 MR. SCHECK:

Your Honor, I would like to ask that these five pages be marked as Defendant's next in order.

208 THE CLERK:

1185.

209 MR. SCHECK:

1185.

210 (Deft's 1185 for id = 5-page serology notes)
211 MR. SCHECK:

Now, I show you these serology item description notes--

212 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
213 MR. SCHECK:

--five pages, and ask you to look at them and tell me if I have them in the order in which you wrote them?

214 MR. YAMAUCHI:

No, I don't believe so.

215 MR. SCHECK:

All right. Would you please put them in the order in which you wrote them and mark the first page as 1 and go through 5.

216 (Witness complies.)
217 MR. SCHECK:

Now, Mr. Yamauchi, do you think it is good laboratory practice not to note--withdrawn. Do you think it is good laboratory practice not to write contemporaneously the number on your note pages?

218 MR. YAMAUCHI:

On descriptive notes, no, I don't think it is necessary.

219 MR. SCHECK:

How do you know, sitting here today, which of these you wrote in what order?

220 MR. YAMAUCHI:

I told you that is the way I believe it to be, to the best--and that is to the best of my recollection.

KEY QUOTE
221 MR. SCHECK:

Now, did you figure this out, the order, in terms of what--how you wanted to--what--withdrawn. Did you number these pages in a way that would be consistent with a reconstruction of events that you think would be good for your testimony?

222 MR. HARMON:

Objection. That is argumentative and misstates his testimony.

223 THE COURT:

Sustained, sustained.

224 MR. SCHECK:

Do you have some concern, Mr. Yamauchi, that your analysis of the glove, your sampling from the glove, could have occurred between 9:00 and ten o'clock that morning?

225 MR. YAMAUCHI:

Do I have some concern?

226 MR. SCHECK:

Yeah.

227 MR. YAMAUCHI:

Well, I don't have notes as to what time I sampled that.

KEY QUOTE
228 MR. SCHECK:

You don't, do you?

229 MR. YAMAUCHI:

No, I don't.

230 MR. SCHECK:

And you testified on direct examination that you think it happened some time in the morning, maybe in the afternoon?

231 MR. YAMAUCHI:

Well, if you are reading from an official transcript and that is what I said, then yeah, that sounds about right, approximately.

232 MR. SCHECK:

Well, Mr. Yamauchi, could you have analyzed cut samples from the glove between 9:00 and ten o'clock that morning?

233 MR. YAMAUCHI:

Well, according to my notes I was sampling the other swatches, so I don't think that is--that is very likely. I would have been working on that.

234 MR. SCHECK:

Well, your notes indicate that you sampled the Bundy blood drops between 10:00 and 11:00?

235 MR. YAMAUCHI:

Yes.

236 MR. SCHECK:

And that you sampled the two exemplars from Miss Nicole Brown Simpson and Ronald Goldman between 11:00 and 11:20?

237 MR. YAMAUCHI:

The--well, they were--you mean the samples that were taken at the scene at that point to act in lieu of having the actual exemplars? Yes.

238 MR. SCHECK:

And you had a conversation that morning with Mr. Matheson and Mr. Fung at around 7:30, eight o'clock?

239 MR. YAMAUCHI:

That is not in my notes, but that is approximately--I talked to Greg somewhere in there or Greg and Dennis.

240 MR. SCHECK:

Have you looked at Mr. Matheson's notes as to what time he recalls the conversation occurring?

241 MR. YAMAUCHI:

No, I haven't seen his notes.

242 MR. SCHECK:

Have you discussed it with him?

243 MR. YAMAUCHI:

Discussed what time I talked to him?

244 MR. SCHECK:

Yeah, when a meeting occurred between you and him that morning?

245 MR. YAMAUCHI:

No.

246 MR. SCHECK:

Now--your Honor, may I put page 1 of 1185, as he has numbered it, on the elmo?

247 THE COURT:

Yes.

248 (Brief pause.)
249 MR. SCHECK:

Now, let's start reading page 1 of 1185 from the top. Mr. Harris, could you just move it a little to the left.

250 (Brief pause.)
251 MR. SCHECK:

No, no, I meant to the right. All right.

252 MR. SCHECK:

At the top you indicate here "117, 115, 114, 112." Now, those are the photo identification numbers for the Bundy swatches, correct?

253 MR. YAMAUCHI:

Yes.

254 MR. SCHECK:

And then you indicate to the right of that, "From driveway, from walkway, from walkway" and then you have, what do you call it, ditto marks underneath it?

255 MR. YAMAUCHI:

Yes.

256 MR. SCHECK:

And then you have grouped there "Victim's residence," right?

257 MR. YAMAUCHI:

Right.

258 MR. SCHECK:

And that reflects the notes you took on your conversation with Mr. Fung that morning on what he was telling you those samples represented?

259 MR. YAMAUCHI:

Yes.

260 MR. SCHECK:

And then below that you have "106 and 107" and those reflect the exemplars from Mr. Goldman and Miss Simpson?

261 MR. YAMAUCHI:

Well, what would at that time be used in place of them, yes.

262 MR. SCHECK:

And one of them indicates "Off the stump," the other one indicates "Concrete."

263 MR. YAMAUCHI:

Yes.

264 MR. SCHECK:

And then you have next to that, "These samples not true exemplars," right?

265 MR. YAMAUCHI:

Right.

266 MR. SCHECK:

And then the next thing you wrote is "Glove," right? Can you read that line to us?

267 MR. YAMAUCHI:

"No. 9"--"No. 9 glove" and then there is "Brn," I think that means brown, because that is what--these are all my notes. That means brown. "Brown glove with red stain as per Fung" and then in parentheses "Via RHD O.J.'s cut on left hand" and then underneath "Next page."

268 MR. SCHECK:

What does that say underneath?

269 MR. YAMAUCHI:

"Next page."

270 MR. SCHECK:

Next page, but the next page that you numbered for me just a minute ago is your drawings of the Bundy swatches, right?

271 MR. YAMAUCHI:

Yes.

272 MR. SCHECK:

And page 3 of what you numbered for me is a diagram of the glove?

273 MR. YAMAUCHI:

Yes.

274 MR. SCHECK:

So Mr. Yamauchi, when you put down "Glove" and then "Next page" under that, were you not referring to the diagram you made of the glove?

275 MR. YAMAUCHI:

You know, that makes good sense. That is probably the order that went in.

276 MR. SCHECK:

So page 3 is page 2, isn't it?

277 MR. HARMON:

Objection. How could that be?

278 THE COURT:

Overruled. Do you understand the question?

279 MR. YAMAUCHI:

Yeah. If you are talking--referring to the numbers, yeah, you had me put on the pages, yes, but once again, I don't number my pages.

280 MR. SCHECK:

I understand, but looking at your notes and reconstructing it now, what you labeled as page 3 should be page 2?

281 MR. YAMAUCHI:

It seems that way, yes.

282 MR. SCHECK:

All right. Do you mind if I renumber them with the Court's permission?

283 MR. YAMAUCHI:

Go right ahead. Sure.

284 (Brief pause.)
285 MR. SCHECK:

Now, turning back to page 1, the next entry down refers to Mr. Simpson's blood vial, reference tube?

286 MR. YAMAUCHI:

Yes.

287 MR. SCHECK:

And indicates what you did underneath that is you wrote down what you saw on the outside of the tube? Isn't that what you did?

288 MR. YAMAUCHI:

Yes, the ones in the quotes.

289 MR. SCHECK:

And then what appears to be the bottom right-hand side as we are looking on the screen you have a line that indicates "Used about one milliliter for swatching," correct?

290 MR. YAMAUCHI:

Yes.

291 MR. SCHECK:

Now, looking at your notes now, Mr. Yamauchi, in terms of the order in which you listed the items, does it not appear that you handled the glove, as your diagram on what we now agree as page 2 indicates, you sampled the glove before you did the Bundy swatches?

292 MR. YAMAUCHI:

Yes, that is possible.

KEY QUOTE
293 MR. SCHECK:

Your Honor, I think this is a good place to stop.

Temperature

devastating

Key Quotes (5)

Collin Yamauchi
Sure, provided you take the precautions that I take.
Yamauchi concedes he handled Simpson's reference tube alongside 23 evidentiary samples in the same session and location, defending only his own technique rather than denying the co-mingling.
Barry Scheck
To assure that no contamination occurs between known samples and evidentiary samples in a case, the exemplars and evidentiary samples are extracted at different times and/or locations.
Scheck reads Yamauchi's own lab protocol section 25 back to him, establishing that his actual conduct directly contradicted his written quality assurance standards.
Collin Yamauchi
Yes, that is possible.
Yamauchi concedes, when confronted with his own notes, that he may have sampled the glove before the Bundy swatches — placing the high-DNA reference blood in close temporal proximity to the glove evidence.
Collin Yamauchi
Well, I don't have notes as to what time I sampled that.
Admission that his note-keeping was insufficient to establish the order or timing of critical evidence handling.
Collin Yamauchi
I told you that is the way I believe it to be, to the best — and that is to the best of my recollection.
Yamauchi admits the page ordering of his own lab notes is based on memory, not documentation — undermining the reliability of his account of the June 14th sample sequence.

Evidence (6)

Defendant's 1185
Five pages of Yamauchi's handwritten serology item description notes from June 14th — unnumbered and out of order
Introduced and used to challenge the sequence and timing of Yamauchi's sample handling
Informal
LAPD crime lab protocol section 25, Quality Assurance Program — containing language requiring exemplars and evidentiary samples be extracted at different times and/or locations
Shown to witness to refresh recollection; used to establish that Yamauchi's conduct violated his own written protocol
Informal
OJ Simpson's reference blood vacutainer tube
Discussed as high-DNA-content exemplar handled in the same extraction session as Bundy evidentiary samples on June 14th
Informal
Bundy blood drop swatches (items 117, 115, 114, 112 — from driveway and walkway)
Referenced in notes; timing of sampling relative to glove and reference tube examined
Informal
Brown glove with red stain (item 9, 'via RHD, OJ's cut on left hand')
Yamauchi's diagram identified as likely page 2 of his notes, suggesting the glove was sampled before the Bundy swatches
Informal
Scene samples from Nicole Brown Simpson and Ronald Goldman (items 106 and 107, noted as 'not true exemplars')
Referenced in notes; Yamauchi confirms these were used in lieu of actual exemplars

Notable Exchanges (4)

Barry ScheckCollin Yamauchi
Scheck reads protocol section 25 back to Yamauchi — 'exemplars and evidentiary samples are extracted at different times and/or locations' — then methodically establishes that Yamauchi extracted Simpson's reference blood, the glove, and the Bundy swatches all in the same lab, in the same session, within roughly 90 minutes. Yamauchi's only defense is his one-at-a-time handling technique.
strategic
Barry ScheckCollin Yamauchi
Scheck asks Yamauchi to put his five unnumbered note pages in order and number them. Yamauchi complies, then is shown through internal logic ('Next page' notation following the glove entry) that his own numbering was wrong — the glove diagram should be page 2, not page 3 — implying the glove was processed before the Bundy swatches.
revealing
Collin YamauchiBarry Scheck
Yamauchi attempts to add to an answer and Scheck cuts him off. Yamauchi says 'Can I finish?' Scheck replies 'I thought you had.' Harmon intervenes noting the witness was going to embellish; Ito tells Yamauchi to answer the question.
tense
Barry ScheckCollin Yamauchi
Scheck asks directly whether Yamauchi numbered his notes in a way 'that would be consistent with a reconstruction of events that you think would be good for your testimony.' Harmon objects and is sustained, but the implication hangs in the air.
heated

Light Moments (2)

Barry Scheck
Scheck tells the camera operator 'Move it a little to the left' then immediately corrects himself — 'No, no, I meant to the right.'
Rockne Harmon
After Scheck suggests page 3 should actually be page 2, Harmon objects with 'Objection. How could that be?' — an unusually colloquial objection that Ito simply overruled.

Credibility Attacks (3)

⚔ Collin Yamauchi
Protocol violation / prior inconsistent conduct
Scheck established that Yamauchi's own written protocol (section 25) requires exemplars and evidentiary samples to be extracted at different times and/or locations, then showed Yamauchi extracted Simpson's reference blood alongside Bundy evidentiary samples in the same lab, same hood, same 90-minute session on June 14th.
⚔ Collin Yamauchi
Inadequate documentation / reconstructed testimony
Yamauchi's five note pages were unnumbered and he could not say with certainty what order he wrote them in. When forced to number them, Scheck demonstrated through internal references in the notes that his ordering was wrong, suggesting his account of the sample sequence was reconstructed from memory rather than contemporaneous records.
⚔ Collin Yamauchi
Admission against interest
After Scheck worked through the note structure, Yamauchi conceded that 'yes, that is possible' when asked whether he sampled the glove before the Bundy swatches — placing the high-concentration reference blood handling in close temporal proximity to the key physical evidence.

Witness Demeanor

(No audible response.) — twice, when asked about note detail importance and page count
Witness complies — when asked to reorder and number his note pages
Repeatedly gives extended procedural explanations rather than yes/no answers, prompting Ito and Scheck to cut him off multiple times

Objections

16 objections (10 sustained, 5 overruled)
Proceeding 6215 • 293 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 30, 1995 📄 Cross-examination of Collin Ya
MAY 30, 1995 KRT DvH TD